Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00269373|
Recruitment Status : Completed
First Posted : December 23, 2005
Last Update Posted : February 22, 2012
|Condition or disease||Intervention/treatment|
|Unknown Primary Tumor||Procedure: PET-CT|
Patients who fulfill the international definition of unknown primary tumors can be included, except:
- Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.
- Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included.
- Women with adenocarcinoma in lymph nodes in the axilla will not be included.
|Study Type :||Observational|
|Actual Enrollment :||136 participants|
|Official Title:||PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors|
|Study Start Date :||December 2005|
|Actual Primary Completion Date :||February 2012|
|Actual Study Completion Date :||February 2012|
- Procedure: PET-CT
no drugs included
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00269373
|Copenhagen, Denmark, 2100|
|Principal Investigator:||Gedske Daugaard||Rigshospitalet, Denmark|